#USA #Toronto #Drug Development #RNA Therapeutics #Xtalks

Insight into RNA Drug Development

Advancements in RNA-based therapeutics hinge on elucidating pivotal aspects of drug candidates: their destination and functionality within the body. Addressing these vital questions is the core focus of an upcoming webinar hosted by Xtalks, titled "Detecting and Characterizing RNA Drug Candidates to Accelerate Therapeutic Development."

In this informative session, participants will gain valuable insights into universal strategies for detecting chemical modifications in oligonucleotide therapeutics. The platform will reveal methodologies for mapping small RNA-target interactions throughout the entire transcriptome. The discussion features industry experts who will share their knowledge of combined localization with functional assays, which together furnish a comprehensive perspective on the behavior of RNA therapies.

Webinar Highlights

Attendees will engage with various analytical tools that contribute to a thorough understanding of RNA therapeutics. The webinar will emphasize the importance of integrating complementary analytics to illuminate the journey of RNA drug candidates from discovery to development. Key topics will include:

• - How to effectively utilize sensitive antibody detection panels for universal identification of significant chemical modifications in various oligonucleotide modalities such as ASOs and siRNA.
• - The relevance of next-generation sequencing and data-driven strategies in mapping small RNA-target interactions across the transcriptome. This process elucidates binding locations, influences on RNA processing and downstream effects on gene expression, thereby informing specificity and efficacy.

Furthermore, combined approaches are depicted as essential in reducing the risks associated with candidate selection and refining delivery strategies, which are often critical in therapeutic development pathways.

Key Speakers

Industry leaders Todd Giardiello, Business Development Manager at Rockland Immunochemicals, Inc., and Diana Cox, PhD, Senior Scientist at Eclipsebio, will host this pivotal webinar scheduled for January 28, 2026, at 1 PM EST (10 AM PST). Their expertise promises to enhance understanding for all attendees, regardless of their level of familiarity with the subject.

Why Attend?

This webinar is an excellent opportunity for professionals engaged in the pharmaceutical, biotechnology, and healthcare sectors to stay abreast of innovations in RNA therapeutics. Whether you are involved in research, drug development, or regulatory compliance, the insights provided during this session can greatly benefit your understanding of the current landscape of RNA drug candidates and the technologies driving their advancement.

To register for this enlightening session and learn how effective detection and characterization strategies can propel RNA therapeutic development, visit the official Xtalks webinar page.

Xtalks has built a reputation as a leading provider of educational webinars and digital content tailored for professionals in life sciences and healthcare, allowing thousands to gain accessible knowledge about industry developments, regulations, and best practices each year.

For further details regarding hosting a webinar or more information about Xtalks, please explore their website. Don’t miss this opportunity to expand your knowledge and understanding of RNA drug candidates!